[Health Technology Assessment: a value-based tool for the evaluation of healthcare technologies. Reassessment of the cell-culture-derived quadrivalent influenza vaccine: Flucelvax Tetra<sup>®</sup> 2.0].

Calabrò GE, Boccalini S, Bechini A, Panatto D, Domnich A, Lai PL, Amicizia D, Rizzo C, Pugliese A, DI Pietro ML, Zanella B, Parente F, Trombetta CS, Saraceno G, Sottile S, Abreha FM, Giacchetta I, Properzi S, Santolini G, D'Ambrosio F, Maida A, Scardigno A, LA Gatta E, Petrella L, Bonanni P, DE Waure C.

Open source

DOI: 10.15167/2421-4248/jpmh2022.63.4s1
Published: 2022-12-01
Container: J Prev Med Hyg
Publisher: Journal of Preventive Medicine and Hygiene
Open access: yes

Credibility signals

uncertain Score 51/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.15167/2421-4248/jpmh2022.63.4s1,
  title = {[Health Technology Assessment: a value-based tool for the evaluation of healthcare technologies. Reassessment of the cell-culture-derived quadrivalent influenza vaccine: Flucelvax Tetra<sup>®</sup> 2.0].},
  author = {Calabrò GE and  Boccalini S and  Bechini A and  Panatto D and  Domnich A and  Lai PL and  Amicizia D and  Rizzo C and  Pugliese A and  DI Pietro ML and  Zanella B and  Parente F and  Trombetta CS and  Saraceno G and  Sottile S and  Abreha FM and  Giacchetta I and  Properzi S and  Santolini G and  D'Ambrosio F and  Maida A and  Scardigno A and  LA Gatta E and  Petrella L and  Bonanni P and  DE Waure C.},
  year = {2022},
  journal = {J Prev Med Hyg},
  doi = {10.15167/2421-4248/jpmh2022.63.4s1},
  url = {https://doi.org/10.15167/2421-4248/jpmh2022.63.4s1}
}

RIS

TY  - JOUR
TI  - [Health Technology Assessment: a value-based tool for the evaluation of healthcare technologies. Reassessment of the cell-culture-derived quadrivalent influenza vaccine: Flucelvax Tetra<sup>®</sup> 2.0].
AU  - Calabrò GE
AU  -  Boccalini S
AU  -  Bechini A
AU  -  Panatto D
AU  -  Domnich A
AU  -  Lai PL
AU  -  Amicizia D
AU  -  Rizzo C
AU  -  Pugliese A
AU  -  DI Pietro ML
AU  -  Zanella B
AU  -  Parente F
AU  -  Trombetta CS
AU  -  Saraceno G
AU  -  Sottile S
AU  -  Abreha FM
AU  -  Giacchetta I
AU  -  Properzi S
AU  -  Santolini G
AU  -  D'Ambrosio F
AU  -  Maida A
AU  -  Scardigno A
AU  -  LA Gatta E
AU  -  Petrella L
AU  -  Bonanni P
AU  -  DE Waure C.
PY  - 2022
JO  - J Prev Med Hyg
DO  - 10.15167/2421-4248/jpmh2022.63.4s1
UR  - https://doi.org/10.15167/2421-4248/jpmh2022.63.4s1
ER  -

APA

GE, C., S, B., A, B., D, P., A, D., PL, L., D, A., C, R., A, P., ML, D. P., B, Z., F, P., CS, T., G, S., S, S., FM, A., I, G., S, P., G, S., F, D., A, M., A, S., E, L. G., L, P., P, B., & C., D. W. (2022). [Health Technology Assessment: a value-based tool for the evaluation of healthcare technologies. Reassessment of the cell-culture-derived quadrivalent influenza vaccine: Flucelvax Tetra<sup>®</sup> 2.0].. J Prev Med Hyg. https://doi.org/10.15167/2421-4248/jpmh2022.63.4s1

Source records

europe-pmc · retrieved 2026-09-27T02:26:36.639Z
datacite · retrieved 2026-09-27T02:26:36.606Z